<DOC>
	<DOCNO>NCT02491112</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy Luliconazole Cream 1 % apply topically 7 day pediatric subject 2 year 17 year age tinea corporis .</brief_summary>
	<brief_title>A Randomized Study Evaluating Safety Efficacy Luliconazole Cream Pediatric Subjects With Tinea Corporis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<criteria>1 . Subjects ( legal guardian ) ability willingness sign write informed consent and/or assent ( age appropriate ) . 2 . Subjects either gender must 2 year &lt; 18 year age ( 2 17 year age , inclusive ) . 3 . Subjects clinical diagnosis tinea corporis characterize clinical evidence tinea infection 4 . Subjects must good general health free disease Investigator 's opinion might interfere study evaluation . 1 . Subjects active atopic contact dermatitis treatment area . 2 . Subjects severe dermatophytoses , mucocutaneous candidiasis , bacterial skin infection . 3 . Female subject pregnant and/or nursing planning pregnancy course trial . 4 . Subjects immunocompromised ( due disease , e.g. , HIV medication ) .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>